4.6 Article

Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons

期刊

PLOS MEDICINE
卷 16, 期 8, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pmed.1002882

关键词

-

资金

  1. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [UM1AI069465, R01AI097494]
  2. NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [RO1HD081929, R01HD074944]
  3. NIH/NIAID/AmFAR [U01AI069907]
  4. Ujala Foundation
  5. Gilead Foundation
  6. Wyncote Foundation
  7. NIH [2UM1AI069521-08, UM1AI068634, UM1AI068636, UM1AI106701]
  8. IMPAACT/IMPAACT network through the NIH NIAID/NICHD/National Institute of Mental Health (NIMH) [UM1AI068632, UM1AI068616, UM1AI106716]
  9. NICHD [HHSN275201800001I]
  10. NIH NICHD [R01HD083047]
  11. MRC [MR/M007340/1] Funding Source: UKRI

向作者/读者索取更多资源

Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据